Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study
The study aimed to compare the effectiveness and safety of ultrasound-guided microwave ablation (MWA) and percutaneous sclerotherapy (PS) for the treatment of large hepatic hemangioma (LHH). This retrospective study included 96 patients who underwent MWA ( = 54) and PS ( = 42) as first-line treatm...
Saved in:
Published in: | International journal of hyperthermia 2024, Vol.41 (1), p.2285705-2285705 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The study aimed to compare the effectiveness and safety of ultrasound-guided microwave ablation (MWA) and percutaneous sclerotherapy (PS) for the treatment of large hepatic hemangioma (LHH).
This retrospective study included 96 patients who underwent MWA (
= 54) and PS (
= 42) as first-line treatment for LHH in three tertiary hospitals from January 2016 to December 2021. Primary outcomes were technique efficacy rate (volume reduction rate [VRR] > 50% at 12 months), symptom relief rate at 12 months and local tumor progression (LTP). Secondary outcomes included procedure time, major complications, treatment sessions, cost and one-, two-, three-year VRR.
During a median follow-up of 36 months, the MWA group showed a higher technique efficacy rate (100% vs. 90.4%,
= .018) and symptom relief rate (100% vs. 80%,
= .123) than the PS group. The MWA group had fewer treatment sessions, higher one-, two- and three-year VRR, lower LTP rate (all
|
---|---|
ISSN: | 0265-6736 1464-5157 |